Treatment of low-grade gliomas in children: an update

References

• Pollack IF Brain tumors in children. N Engl. J. Med. 331(22), 1500–1507 (1994).
   Google Scholar
• Rekate HL, Rakfal SM. Low-grade astrocytomas of childhood. Neurol. Clin. 9(2), 423–440 (1991).
   PubMed Web of Science ®Google Scholar
• Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int. I Radiat. Oncol. Biol. Phys. 51(3), 704–710 (2001).
   Google Scholar
• Perilongo G, Garre ML, Giangaspero E Low-grade glioma and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv. Syst. 19 (4), 197–203 (2003).
   Web of Science ®Google Scholar
• Stupp R, Baumert BG. Promises and controversies in the management of low-grade glioma. Ann. Oncol. 14(12), 1695–1696 (2003).
   PubMed Web of Science ®Google Scholar
• Rashidi M, DaSilva VR, Minagar A, Rutka JT. Nonmalignant pediatric brain tumors. CUIT: Neurol. Neurosci. Rep. 3(3), 200–205 (2003).
   Google Scholar
• Rilliet B, Vernet O. Gliomas in children: a review. Childs Nerv. Syst. 16(10-11), 735–741 (2000).
   Web of Science ®Google Scholar
• •Good overview of gliomas in children, including both low and high grade.
   Google Scholar
• Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150(1), 1–13 (1997).
   Google Scholar
• Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv. Syst. 16(7), 417–420 (2000).
   Google Scholar
• Willert JR, Daneshvar L, Sheffield VC, Cogen PH. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas. ants Chromosomes Can. 12(3), 165–172 (1995).
   Google Scholar
• Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto AL. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst. 19(4), 232–243 (2003).
   Google Scholar
• Kieran MW Advances in pediatric neuro-oncology. CUIT: Opin. Neural. 13(6), 627–634 (2000).
   Google Scholar
• •Discussess of technological advances in pediatric neuro-oncology.
   Google Scholar
• Rubin JB, Kieran MW Innovative therapies for pediatric brain tumors. CUIT: Opin. Pediatr 11(1), 39–46 (1999).
   Google Scholar
• •Discussess the preclinical and novel approaches that are on the horizon for pediatric brain tumor patients.
   Google Scholar
• Giangaspero F, Kaulich K, Cenacchi G et al. Lipoastrocytoma: a rare low-grade astrocytoma variant of pediatric age. Acta Neuropathol. (Berl) 103(2), 152–156 (2002).
   Google Scholar
• Kleihues P, Cavenee WK (Eds). Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours. IARC Press: Lyon, France (2000).
   Google Scholar
• ••Provides a simple yet informativesummary of all major classes of brain tumors. While based on adult lesions, most pediatric tumors are included.
   Google Scholar
• Yachnis AT. Neuropathology of pediatric brain tumors. Semin. Pediatr. Neurol. 4(4), 282–291 (1997).
   Google Scholar
• Dirven CM, Koudstaal J, Mooij JJ, Molenaar WM. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuroradiological follow-up. I Neurooncol. 37(1), 9–16 (1998).
   Google Scholar
• Korshunov A, Golanov A. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute. Neurooncol. 52(1), 63–72 (2001).
   Google Scholar
• Sugita Y, Shigemori M, Okamoto K, Morimatsu M, Arakawa M, Nakayama K. Clinicopathological study of pleomorphic xanthoastrocytoma: correlation between histological features and prognosis. Pathol. Int. 50(9), 703–708 (2000).
   PubMed Web of Science ®Google Scholar
• Giannini C, Scheithauer BW, Burger PC et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 85(9), 2033-2045 (1999).
   Google Scholar
• Orr LC, Fleitz J, McGavran L, Wyatt- Ashmead J, Handler M, Foreman NK. Cytogenetics in pediatric low-grade astrocytomas. Med. Pediatr. Oncol. 38(3), 173–177 (2002)
   Google Scholar
• Shafqat S, Hedley-Whyte ET, Henson RV. Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology52 (4), 867–869 (1999).
   PubMed Web of Science ®Google Scholar
• Darling JL, Warr TJ. Biology and genetics of malignant brain tumours. CUIT: Opin. Neurol. 11(6), 619–625 (1998).
   Web of Science ®Google Scholar
• Rizk T, Mottolese C, Bouffet E et al. Pediatric oligodendrogliomas. Pediatr. Neurosurg. 30(3), 166 (1999).
   PubMed Web of Science ®Google Scholar
• Turgut M, Tahta K, Ozcan OE, Onol B. The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases. Neurosurg. Rev 21(2-3), 138–146 (1998).
   PubMed Web of Science ®Google Scholar
• Razack N, Baumgartner J, Bruner J. Pediatric oligodendrogliomas. Pediatr. Neurosurg. 28(3), 121–129 (1998).
   Google Scholar
• Kedar A. Chemotherapy for pediatric brain tumors. Semin. Pediatr. Neurol. 4 (4), 320–332 (1997).
   Google Scholar
• Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology. Surg. Neurol. 58(2), 111–117 (2002).
   Google Scholar
• Raghavan R, Balani J, Perry A etal. Pediatric oligodendrogliomas: a study of molecular alterations on lp and 19q using fluorescence in situ hybridization. I Neuropathol. Exp. Neurol. 62(5), 530–537 (2003).
   Google Scholar
• ••Raises a number of issues regardingchromosomal abnormalities in adult versus pediatric tumors of the same type. With an increasing number of publications on the subclassification of oligodendroglial tumors and their treatments, understanding these differences become more important.
   Google Scholar
• Hussein MR, Baidas S. Advances in diagnosis and management of oligodendroglioma. Expert Rev Anticancer Ther. 2(5), 520–528 (2002).
   Google Scholar
• Johnson JH Jr, Hariharan S, Berman J et al. Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr. Neurosurg. 27(4), 203–207 (1997).
   Google Scholar
• Tamburrini G, Colosimo C Jr, Giangaspero F, Riccardi R, Di Rocco C. Desmoplastic infantile ganglioglioma. Childs Nerv. Syst. 19(5-6), 292–297 (2003).
   Web of Science ®Google Scholar
• Cabiol J, Acebes JJ, Isamat E Dysembryoplastic neuroepithelial tumor. Crit. Revs. Neurosurg. 9(2), 116–125 (1999).
   Google Scholar
• Zentner J, Hufnagel A, Wolf HK et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41 (2), 378–386 (1997).
   PubMed Web of Science ®Google Scholar
• Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23(5) 545–556 (1988).
   Google Scholar
• Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. I Neuropathol. Exp. Neural 54(2), 245–254 (1995).
   Google Scholar
• Vuori K, Kankaanranta L, Hakkinen AM etal. LGGs and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology230 (3), 703–708 (2004).
   PubMed Web of Science ®Google Scholar
• Maehara T, Nariai T, Arai N et aL Usefulness of [11C]methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia 45(1), 41–45 (2004).
   Google Scholar
• Fernandez C, Girard N, Paz Paredes A, Bouvier-Labit C, Lena G, Figarella-Branger D. The usefulness of MR imaging in the diagnosis of dysembryoplastic neuroepithelial tumor in children: a study of 14 cases. AJNR Am. J NeuroradioL 24(5), 829–834 (2003).
   Google Scholar
• Stanescu Casson R, Varlet P, Beuvon F et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J. NeuroradioL 28(4), 230–240 (2001).
   Google Scholar
• Cenacchi G, Giangaspero E Emerging tumor entities and variants of CNS neoplasms. J. NeuropathoL Exp. NeuroL 63(3), 185–192 (2004).
   Google Scholar
• ••Discusses many of the new and rare braintumors not yet incorporated into the World Health Organization classification. If you are looking for a tumor and can not find it discussed in the standard text, this is the place to look.
   Google Scholar
• MM KW, Cashman RE, Brumback RA. Glioneurocytoma: tumor with glial and neuronal differentiation. J. Child. NeuroL 10(3),219–226 (1995).
   Google Scholar
• Desai KI, Nadkarni TD, Muzumdar DP, Goel A. Prognostic factors for cerebellar astrocytomas in children: a study of 102 cases. Pediatr. Neurosurg. 35 (6), 311–317 (2001).
   Google Scholar
• Gajjar A. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J. Clin. OncoL 15(8), 2792–2799 (1997).
   Google Scholar
• Fouladi M, Jenkins J, Burger P etal. Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-oncology3(3), 184–192 (2001).
   PubMed Web of Science ®Google Scholar
• Walker D. Recent advances in optic nerve glioma with a focus on the young patient. Curl: Opin. NeuroL 16(6), 657–664 (2003).
   Web of Science ®Google Scholar
• ••Good review of optic gliomas, one of themost common low-grade gliomas (LGGs) in pediatrics.
   Google Scholar
• Daglioglu E, Cataltepe O, Akalan N. Tectal gliomas in children: the implications for natural history and management strategy. Pediatr. Neurosurg. 38(5), 223–231 (2003).
   Google Scholar
• Sun B, Wang CC, Wang J. MRI characteristics of midbrain tumours. Neuroradiology 41(3), 158–162 (1999).
   PubMed Web of Science ®Google Scholar
• Young Poussaint T. Cervicomedullary astrocytomas of childhood: clinical and imaging follow-up. Pediatr. RadioL 29(9), 662–668 (1999).
   PubMed Web of Science ®Google Scholar
• Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int. J. Radiat. OncoL Biol. Phys. 40(2), 265–271 (1998).
   Google Scholar
• Warren KE. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J. Clin. OncoL 18(5), 1020–1026 (2000).
   Google Scholar
• Lazareff JA, Bockhorst KH, Curran J, Olmstead C, Alger JR. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43(4), 809–817 (1998).
   PubMed Web of Science ®Google Scholar
• Korf BR. Diagnosis and management of neurofibromatosis Type 1. CUIT: NeuroL Neurosci. Rep. 1(2), 162–167 (2001).
   Google Scholar
• ••Neurofibromatosis Type 1 is one of themost common genetic diseases in North America and 15% of these individuals will have an optic glioma. Treatment strategies for neurofibromatosis Type 1 patients differ significantly from other patients and this article discusses many of the unique factors in this patient population.
   Google Scholar
• Guillamo JS. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): aretrospective study of 104 patients. Brain 126\(Pt 1), 152–160 (2003).
   Google Scholar
• Singhal S, Birch JM, Kerr B, Lashford L, Evans DG. Neurofibromatosis Type 1 and sporadic optic gliomas. Arch. Dis. Child. 87(1), 65–70 (2002).
   Google Scholar
• Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr. NeuroL 28(4), 262–270 (2003).
   PubMed Web of Science ®Google Scholar
• Wellons JC III. Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas. Neurosurgery 51(1) 63–68 (2002).
   PubMed Web of Science ®Google Scholar
• •The increasing expertise with this technique and decreased acute and long-term morbidity make it an important component of neurosurgical care. Centers unable to perform this technique should consider referral to a larger program where it is available.
   Google Scholar
• Pollack IF, Pang D, Albright AL. The long- term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J. Neurosurg. 80(4), 681–688 (1994).
   Google Scholar
• Bowers DC. Tectal gliomas: natural history of an indolent lesion in pediatric patients.Pediatr. Neurosurg. 32(1), 24–29 (2000).
   Web of Science ®Google Scholar
• Packer RJ. Diagnosis and treatment of pediatric brain tumors. CUIT: Opin. NeuroL 7(6), 484–491 (1994).
   Web of Science ®Google Scholar
• Pollack IF. The role of surgery in pediatric gliomas. Neuroonca. 42(3), 271–288 (1999).
   Google Scholar
• ••Excellent overview of surgical options inpediatric patients with CNS tumors.
   Google Scholar
• Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur. Pediatr. 159(9), 692–696 (2000).
   Google Scholar
• Hoffman HJ. Brainstem gliomas. Clin. Neurosurg. 44,549–558 (1997).
   PubMedGoogle Scholar
• Meyer EA, Kieran MW Psychological adjustment of 'surgery-only' pediatric neuro-oncology patients: a retrospective analysis. Psychooncology11(1), 74–79 (2002).
   PubMed Web of Science ®Google Scholar
• •Limited study on surgery-only patients with LGG which demonstrates that even those thought to be the lucky ones demonstrated effects from having a tumor and surgery.
   Google Scholar
• Lagares A, Gomez PA, Lobato RD, Ricoy JR, Ramos A, de la Lama A. Ganglioglioma of the brainstem: report of three cases and review of the literature. Surg. NeuroL 56(5), 315–322 (2001).
   Google Scholar
• Disabato JA, Handler MH, Strain JD, Fleitz JM, Foreman NK. Successful use of intracavitary bleomycin for low-grade astrocytoma tumor cyst. Pediatr. Neurosurg. 31(5), 246–250 (1999).
   Google Scholar
• •Cystic lesions, while considered nonmalignant, continue to cause a great deal of morbidity. This paper on the use of bleomycin offers a novel therapy for some of these patients.
   Google Scholar
• Bowers DC. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 34(5), 229–234 (2001).
   Google Scholar
• Saran FH, Baumert BG, Khoo VS et al. Stereotactically guided conformal radiotherapy for progressive LGGs of childhood. Int. J. Radiat. OncoL Biol. Phys. 53(1), 43–51 (2002).
   Google Scholar
• Plathow C, Schulz-Ertner D, Thilman C etal. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Int. J. Radiat. OncoL Biol. Phys. 57(4), 996–1003 (2003).
   Google Scholar
• Schulz-Ertner D, Debus J, Lahr F, Frank C, Floss A, Wannenmacher M. Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors. Radiother. OncoL 57(2), 215–223 (2000).
   Google Scholar
• Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE. Long-term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer77 (3), 555–562 (1996).
   Google Scholar
• Merchant TE, Zhu Y, Thompson SJ, Sontag MR, Heideman RL, Kun LE. Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. Int. J Radiat. Oncol. Biol. Phys. 52(2), 325–332 (2002).
   Google Scholar
• •Demonstrates the activity of highly conformal radiation therapy in pediatric patients with LGGs.
   Google Scholar
• Marcus KJ. Stereotactic radiotherapy for localized LGGs in children: final results of a prospective trial. Int. J Radiat. Oncol. Biol. Phys. 57\(Suppl. 2), S196 (2003).
   Google Scholar
• Packer RJ. Brain tumors in children. Arch. Neural. 56(4), 421–425 (1999).
   PubMedGoogle Scholar
• Jenkin D, Danjoux C, Greenberg M. Subsequent quality of life for children irradiated for a brain tumor before age four years. Med. Pediatr. Oncol. 31(6), 506–511 (1998).
   Google Scholar
• Fuchs I, Kreil W, Sutter B, Papaethymiou G, Pendl G. Gamma knife radiosurgery of brainstem gliomas. Acta. Neurochir. 84 (Suppl.), 85–90 (2002).
   Google Scholar
• Hadjipanayis CG, Niranjan A, Tyler- Kabara E, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for well-circumscribed fibrillary grade II astrocytomas: an initial experience. Stereotact. Funct. Neurosurg. 79(1), 13–24 (2002).
   Google Scholar
• Hadjipanayis CG. Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg. 97(1), 56–64 (2002).
   Google Scholar
• Fuss M, Hug EB, Schaefer RA et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int. J Radiat. Oncol. Biol. Phys. 45 (5), 1117–1126 (1999).
   Google Scholar
• Rosenstock JG, Packer RJ, Bilaniuk L, Bruce DA, Radcliffe JL, Savino E Chiasmatic optic glioma treated with chemotherapy. A preliminary report. J Neurosurg. 63(6), 862–866 (1985).
   PubMed Web of Science ®Google Scholar
• Lefkowitz IB. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer 61(5), 896–902 (1988).
   PubMed Web of Science ®Google Scholar
• Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. I Clin. Oncol. 13(8), 2072–2076 (1995).
   Google Scholar
• Kobrinsky NL. Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881. J Neurooncd. 45(1), 47–54 (1999).
   Google Scholar
• Packer RJ, Ater J, Allen J etal. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive LGGs. Neurosurg. 86(5), 747–754 (1997).
   Web of Science ®Google Scholar
• ••This report (and earlier publications of thesame study) has become the standard of care for patients around the world with LGGs.
   Google Scholar
• Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA. Treatment of pediatric LGGs with a nitrosourea-based multiagent chemotherapy regimen. J. Neurooncol. 32(3), 235–241 (1997).
   PubMed Web of Science ®Google Scholar
• ••Has become the other standard therapy formost LGGs.
   Google Scholar
• Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW Chemotherapy for progressive LGGs in children older than ten years: the Dana-Farber experience. Pediatr. Hematol. Oncol. 20(7), 497–504 (2003).
   Google Scholar
• Gururangan S. Phase II study of carboplatin in children with progressive low-grade glioma. I Clin. Oncol. 20(13), 2951–2958 (2002).
   Google Scholar
• McLaughlin ME, Robson CD, Kieran MW Jacks T, Pomeroy SL, Cameron S. Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation. J. Pediatr. Hematol. Oncol. 25(8), 644–648 (2003).
   Google Scholar
• Quinn JA. Phase II trial of temozolomide in patients with progressive low-grade glioma.j Clin. amyl. 21 (4), 646–651 (2003).
   Google Scholar
• Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. I Pediatr. Hematol. Oncol. 25(5), 372–378 (2003).
   Google Scholar
• ••The addition of temozolomide forrecurrent LGG is under study and is being considered for addition to the vincristine /carboplatin and TPCV therapies discussed above.
   Google Scholar
• Gajjar A. Response of pediatric low grade gliomas to chemotherapy. Pediatr:Neurosurg. 19(3), 113–120 (1993).
   Google Scholar
• Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M. LGGs of the cerebral hemispheres in children: an analysis of 71 cases. J. Neurosurg. 82(4), 536–547 (1995).
   Google Scholar
• Reardon DA. Bithalamic involvement predicts poor outcome among children with thalamic glial tumors. Pediatr. Neurosurg. 29(1), 29–35 (1998).
   PubMed Web of Science ®Google Scholar
• Anderson NE. Late complications in childhood central nervous system tumour survivors. CUIT: Opin. Neurol. 16(6), 677–683 (2003).
   Web of Science ®Google Scholar
• Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH. Health-related quality of life in survivors of tumours of the central nervous system in childhood-a preference-based approach to measurement in a cross-sectional study. Eur. J. Cancer 35(2), 248–255 (1999).
   Google Scholar
• Oeffinger KC. Healthcare of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann. Fam. Med. 2(1), 61–70 (2004).
   Google Scholar
• •Large review of the SEER database demonstrating the long-term morbidities that survivors of brain tumors face. This article again focuses on the need to balance efficacy with long-term impact.
   Google Scholar
• Carpentieri SC, Waber DP, Pomeroy SL et al. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery 52 (6), 1348–1356 (2003).
   PubMed Web of Science ®Google Scholar
• Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr. Neurosurg. 24(1), 24–34 (1996).
   PubMed Web of Science ®Google Scholar
• Robertson PL, Allen JC, Abbott IR, Miller DC, Fidel J, Epstein FJ. Cervicomedullary tumors in children: a distinct subset of brainstem gliomas. Neurology 44(10), 1798–1803 (1994).
   PubMed Web of Science ®Google Scholar